Testing effectiveness (Phase 2)Ended earlyNCT02985801
What this trial is testing
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Who this might be right for
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Massimo Raimondo, M.D. 16